Abstract
RNA interference (RNAi) is a specific and efficient method to silence gene expression in mammalian cells. However, genetic manipulation of primary cells including human hepatocytes by RNAi remained challenging. Therefore an efficient gene transfer protocol to modify gene expression in primary cells by using VSV-G-pseudotyped, EGFP-expressing lentiviral vectors was established. The protocol comprises the production of lentiviral vectors as well as the steps for efficient delivery of short-hairpin RNAs (shRNAs), microRNAs, or antagomiRs to human hepatocytes. With this method the amount of preparative work is reduced, by achieving high transduction efficiencies with low multiplicity of infection (MOI). Depending on the laboratory equipment, we provide two alternative workflows. The procedure of lentiviral vector production with subsequent titer determination takes approx. 6–10 working days.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Feidt DM, Klein K, Nussler A et al (2009) RNA-interference approach to study functions of NADPH: cytochrome P450 oxidoreductase in human hepatocytes. Chem Biodivers 6:2084–2091
Thomas M, Burk O, Klumpp B et al (2013) Direct transcriptional regulation of human hepatic cytochrome P450 3A4 by peroxisome proliferator-activated receptor alpha. Mol Pharmacol 83:709–718
Zanger UM, Klein K, Thomas M et al (2014) Genetics, epigenetics, and regulation of drug-metabolizing cytochrome p450 enzymes. Clin Pharmacol Ther 95:258–261
Burns JC, Friedmann T, Driever W et al (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc Natl Acad Sci U S A 90:8033–8037
Ilan Y, Saito H, Thummala NR et al (1999) Adenovirus-mediated gene therapy of liver diseases. Semin Liver Dis 19:49–59
Jover R, Bort R, Gomez-Lechon MJ et al (2001) Cytochrome P450 regulation by hepatocyte nuclear factor 4 in human hepatocytes: a study using adenovirus-mediated antisense targeting. Hepatology 33:668–675
Oehmig A, Klotzbücher A, Thomas M et al (2008) A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries. BMC Genomics 9:4411
Zamule SM, Strom SC, Omiecinski CJ (2008) Preservation of hepatic phenotype in lentiviral-transduced primary human hepatocytes. Chem Biol Interact 173:179–186
Godoy P, Hewitt NJ, Albrecht U et al (2013) Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. Arch Toxicol 87(8):1315–1530
Sastry L, Johnson T, Hobson MJ et al (2002) Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods. Gene Ther 9:1155–1162
Acknowledgements
The EGFP-expressing lentiviral vector pLenti6-GFP was kindly provided by Dr. Martin Kriebel, NMI, Reutlingen. We also thank Igor Liebermann and Britta Klumpp, Stuttgart, for expert technical assistance. This study was supported by the German Federal Ministry of Education and Research (Virtual Liver Network Grant 0315755) and by the Robert Bosch Foundation, Stuttgart, Germany.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Rieger, J.K., Thomas, M. (2016). Introduction of shRNAs, miRNAs, or AntagomiRs into Primary Human Liver Cells Through Lentiviral Vectors. In: Federico, M. (eds) Lentiviral Vectors and Exosomes as Gene and Protein Delivery Tools. Methods in Molecular Biology, vol 1448. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3753-0_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3753-0_6
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3751-6
Online ISBN: 978-1-4939-3753-0
eBook Packages: Springer Protocols